Insider · CIK 0001303311
David McWilliams
Files at GLSI (Greenwich LifeSciences, Inc.). First filing -, latest -.
In brief
David McWilliams files SEC Form 4 as director at GLSI (Greenwich LifeSciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David McWilliams has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | GLSI Greenwich LifeSciences, Inc. | AGrant or award Stock Optionsderivative | +61,984 | $0.00 | $0 | 123,968 | Dec 27, 2024 |
Questions about David McWilliams
Answered from the filings on this page, as of the latest one.
Is David McWilliams buying or selling?
David McWilliams has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David McWilliams's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David McWilliams has 0.
Where does David McWilliams file Form 4?
David McWilliams has filed Form 4 at GLSI (Greenwich LifeSciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.